U.S. Tech Hardware Stock News

Short term performance snapshot W. R. Berkley (WRB) has drawn attention after a recent move in its share price, with the stock last closing at $71.27 and posting gains over the past week and month. See our latest analysis for W. R. Berkley. The recent 1 day share price return of 2.86% extends a positive run that includes a 9.16% 30 day share price return and a 3 year total shareholder return of 94.25%, suggesting momentum has been building over a multi year period. If you are looking beyond...

Tuya (TUYA) is back on investor radars after its Conow brand made a major European debut at Intersolar Europe in Munich, presenting AI driven home energy products and securing a Top Innovation Germany 2026 award. See our latest analysis for Tuya. Despite the Conow launch and Tuya’s visibility at global forums, the stock’s short term share price momentum has been weak, with the 30 day share price return down 14.29% and the year to date share price return down 17.81%. The 3 year total...

In June 2026, Ondas Inc. announced more than US$40,000,000 in new orders, launched multiple autonomous defense systems at Eurosatory, and its subsidiary Sentrycs integrated Cyber-over-RF counter-drone technology into Lockheed Martin’s Sanctum platform. Together with U.K. subsidiary Rotron Aerospace’s long-range precision-strike flight tests and the ONBERG European joint venture, these moves underline Ondas’ push to embed AI-enabled autonomy and counter-UAS capabilities across key defense...

Gilead Sciences (NasdaqGS:GILD) received FDA approval for Trodelvy as a first-line treatment for adult patients with advanced or metastatic triple-negative breast cancer. The approval covers use as monotherapy and in combination with Keytruda for PD-L1 positive disease. Trodelvy is a first-in-class Trop-2 directed antibody-drug conjugate with overall survival data across multiple indications. Gilead Sciences is best known for its antiviral therapies, and Trodelvy illustrates how the company...

If you are wondering whether Robert Half stock offers value at today's price, this article breaks down what the current share price might be implying about the business. The stock recently closed at US$32.76, with gains of 3.7% over the past week and 20.8% over the past month, while longer term returns include a 19.8% gain year to date but declines of 13.7% over 1 year, 49.4% over 3 years and 55.3% over 5 years. Recent news around Robert Half has largely focused on its position within the...

PNC Financial Services Group (NYSE:PNC) has completed the large scale integration of FirstBank. The systems conversion adds 780,000 customers, over 1,620 employees, and 95 branches across Colorado and Arizona. The move significantly expands PNC's presence in the Rocky Mountain region. For investors watching large U.S. regional banks, PNC Financial Services Group now has a broader physical footprint across the West after bringing FirstBank fully onto its platforms. The deal adds a meaningful...

Natera and Eledon Pharmaceuticals announced a partnership to use the Prospera test in a global Phase 3 kidney transplant trial. Prospera will serve as the exclusive molecular monitoring assay for longitudinal surveillance in this large-scale study. The trial focuses on a novel immunosuppression therapy for kidney transplant recipients. Natera, traded as NasdaqGS:NTRA, is extending its reach in transplant diagnostics with this new role for Prospera in a pivotal clinical trial. The company’s...

Darden Restaurants (DRI) just wrapped up FY 2026 with fourth quarter revenue of US$3.7 billion and basic EPS of US$3.57, set against trailing twelve month revenue of US$12.8 billion and EPS of US$9.56. Over recent periods, revenue has moved from US$3.2 billion in Q4 FY 2025 to US$3.7 billion in Q4 FY 2026, while quarterly EPS went from US$2.60 to US$3.57, giving investors a clear view of how the top and bottom lines have tracked into the latest release. With a trailing net margin of 8.7%...

ExlService Holdings (NasdaqGS:EXLS) has agreed to acquire iMerit, a provider of AI model training, reinforcement learning tools, and expert talent. The deal is aimed at broadening EXL's enterprise AI services and integrating iMerit's capabilities into its existing data and analytics platforms. This transaction marks a shift in EXL's business mix toward higher value AI technology offerings for large corporate clients. ExlService Holdings enters this deal with iMerit while its share price...

DexCom is rolling out a redesigned Stelo app in July that aims to provide more accessible and actionable glucose insights to users. The company is preparing to launch Stelo in the UK, Australia, New Zealand, and South Korea, marking a push into new international markets. These moves follow recent FDA clearance for over the counter pediatric use of Stelo in the U.S. DexCom, trading on NasdaqGS:DXCM, is making these product and geographic moves as its stock trades around $70.14. The share...

NetApp launched StorageGRID 12.1, a new release designed for AI scale workloads and modern data use cases. The company expanded its global alliance with CGI to offer subscription based, AI ready data infrastructure across hybrid cloud environments. These moves aim to support enterprises operating across globally distributed settings with higher performance and security for AI and data intensive applications. NetApp (NasdaqGS:NTAP) is drawing fresh attention as it pushes deeper into AI...

If you are wondering whether Yum! Brands stock is offering fair value or hiding a margin of safety, the starting point is to line up its recent share performance with what investors are currently paying for it. The stock last closed at US$156.41, with returns of 2.9% over the past week, 2.9% over the past month, 3.9% year to date, 7.4% over 1 year, 19.6% over 3 years and 46.9% over 5 years. This helps frame how the market has been pricing Yum! Brands over different holding periods. Recent...

Earlier in June 2026, CMA CGM S.A. and Capital Clean Energy Carriers Corp. formed a 50/50 joint venture to build, charter, and operate a 20,000 cbm dual-fuel LNG bunkering vessel, ordered from Nantong CIMC Sinopacific Offshore & Engineering for US$82.8 million with delivery targeted for the third quarter of 2028. This move marks Capital Clean Energy Carriers’ entry into the LNG bunkering market, backed by an expected 12-year time charter with a CMA CGM–TotalEnergies venture that could...

If you are wondering whether Tyler Technologies is attractively priced or still has room to fall, the recent share performance gives a clear starting point for assessing value. The stock last closed at US$294.40, with a gain of 5.6% over the past week, but it remains down 2.7% over the past month, 32.5% year to date and 49.3% over the past year. These moves have come alongside ongoing interest in how Tyler Technologies is positioned in the software sector and how investors are reassessing...

Biogen (NasdaqGS:BIIB) is shifting its focus from older multiple sclerosis and Spinraza products to newer drugs in Alzheimer's, Friedreich’s ataxia, ALS, and depression. The company is leaning on recently launched therapies such as Leqembi, Skyclarys, Qalsody, and Zurzuvae to help offset pressure on its legacy franchises. This transition comes as competition from generics and biosimilars weighs on Biogen’s established revenue base. Biogen sits at the center of several high-profile treatment...

Republic Bancorp (RBCA.A) is back on investors’ radar after its latest earnings report showed revenue declining and missing expectations, while net interest income exceeded forecasts. This highlighted a resilient core banking engine despite sector pressures. See our latest analysis for Republic Bancorp. Since the earnings release, Republic Bancorp’s share price has gained momentum, with a 7 day share price return of 5.45% and a 90 day share price return of 29.14%, while the 3 year total...

Ingevity (NGVT) has drawn fresh attention after recent share price moves, prompting investors to reassess how its current valuation lines up with fundamentals such as segment mix, recent returns and profitability trends. See our latest analysis for Ingevity. The latest move takes Ingevity's share price to $77.12, with a 1-month share price return of 11.88% and a year-to-date share price return of 28.34%. The 1-year total shareholder return of 77.86% contrasts with a 5-year total shareholder...

Strive (ASST) has drawn fresh attention after recent trading left the stock well below its past year level, with both short term moves and longer term declines prompting investors to reassess risk and potential reward. See our latest analysis for Strive. At the latest share price of $11.34, Strive’s 7 day share price return is down 23.64% and the 30 day share price return is down 36.36%, while the 1 year total shareholder return has declined 85.50%. This suggests recent momentum has been...

Electric vehicle headlines are noisy right now, with Rivian warning that companies sticking with fossil fuel priorities may fall behind, while major automakers have written off over $70b in EV projects and US policy shifts have cooled incentives. For investors, that mix of caution and long term ambition can create mispricing, both on the upside and downside. This article looks at three stocks from an EV focused screener that are directly exposed to these news catalysts, each with potential...

Tariffs on digital services are back in the headlines, and this time the threat is a 100% levy on countries that tax large U.S. platforms like Meta, Alphabet, and Amazon. That kind of policy shock can quickly change how investors think about global exposure, profit margins, and where risk is really coming from. This article looks at three large U.S. technology stocks from a dedicated screener that are closely linked to the digital tax debate, and explains how this news could work for or...

Worthington Steel (WS) has just reported FY 2026 results, with Q4 revenue of $929.2 million and a basic EPS loss of $0.98. This caps a trailing twelve month period where revenue totaled $3.4 billion and EPS came in at $0.35. Over recent quarters, the company has seen revenue move from $832.9 million and EPS of $1.13 in FY 2025 Q4 to a range between $769.8 million and $929.2 million, with EPS spanning from $0.21 to a loss of $0.98 in FY 2026. This sets a mixed backdrop for its latest release...

Capstone Energy+ (OTCPK:CGEH) has just wrapped up FY 2026 with fourth quarter revenue of US$23.0 million and basic EPS of US$0.06, alongside trailing twelve month revenue of US$106.0 million and basic EPS of US$0.14 that capture its recent move into profitability. Over the past six reported quarters, revenue has ranged between US$20.1 million and US$28.4 million per quarter, while quarterly EPS has swung from a loss of US$1.79 to a profit of US$0.06. This gives investors a clear view of how...

With BlackRock trading at a last close of US$964.71, many investors are asking a simple question: is the stock pricing in too much optimism, or is the current level still reasonable value for the long term. Over the past week the share price declined 8.1%, adding to a 9.9% fall over the last month and an 11.1% decline year to date, even though the 3 year return sits at 49.5% and the 5 year return at 21.8%. Recent news around BlackRock has focused on its role as a major global asset manager...

Crinetics Pharmaceuticals (CRNX) has attracted fresh attention after recent trading moves, prompting investors to reassess how its clinical-stage pipeline and current share performance might align with individual risk tolerance and time horizon. See our latest analysis for Crinetics Pharmaceuticals. Recent trading has been choppy for Crinetics Pharmaceuticals, with a 1 day share price return of 4.89% and a 90 day share price return of 9%, while the year to date share price return has declined...